Posts

Bimekizumab Gives Lasting Symptom Relief in PsA

In patients with psoriatic arthritis, long-term bimekizumab treatment shows sustained improvement in symptoms and disease impact, according to an analysis of data from two phase 3 trials. Medscape Medical News source https://www.medscape.com/viewarticle/bimekizumab-gives-lasting-symptom-relief-patients-psoriatic-2026a1000itb?src=rss

Anifrolumab Improves Multiple Sjögren Disease Measures

Early data from the ANISE-II study show that the lupus-approved treatment may also work well in managing Sjögren disease. Medscape Medical News source https://www.medscape.com/viewarticle/anifrolumab-improves-multiple-sj%C3%B6gren-disease-measures-2026a1000isz?src=rss

IV Dexamethasone Ranks Best Against Post-Block Rebound Pain

A new analysis ranks intravenous administration of dexamethasone as the most effective approach to prevent rebound pain after peripheral nerve block, whereas preemptive opioids offer little relief. Medscape Medical News source https://www.medscape.com/viewarticle/iv-dexamethasone-ranks-best-against-post-block-rebound-pain-2026a1000in0?src=rss

Nurses Could Be the Key to Better Self-Care for IBD Patients

A nurse-patient ‘mutuality’ shows a positive association with self-care behaviors in adults with inflammatory bowel disease. Medscape Medical News source https://www.medscape.com/viewarticle/nurses-could-be-key-better-self-care-patients-ibd-2026a1000imo?src=rss

Phase 3: Rapid Relief in Thyroid Eye Disease With Veligrotug

A five-infusion course of veligrotug is well tolerated and results in rapid improvements in diplopia, proptosis, and disease activity in patients with thyroid eye disease, a phase 3 trial shows. Medscape Medical News source https://www.medscape.com/viewarticle/phase-3-rapid-relief-thyroid-eye-disease-veligrotug-2026a1000ifw?src=rss

Zurich Heart Surgery Scandal: Device Safety Alert

An independent inquiry links roughly 70 excess deaths at Zurich’s university heart clinic (2016-2020); prosecutors now probe valve-implant use, raising device-safety concerns. Medscape News Europe source https://www.medscape.com/viewarticle/zurich-heart-surgery-scandal-device-safety-alert-2026a1000ifs?src=rss

Nearly 10% AxSpA Patients Meet Difficult-to-Manage Criteria

Approximately 1 in 10 patients with axial spondyloarthritis fulfill the criteria for difficult-to-manage disease; higher spinal pain scores and fibromyalgia are linked to difficult-to-manage disease. Medscape Medical News source https://www.medscape.com/viewarticle/nearly-10-patients-axspa-meet-criteria-difficult-manage-2026a1000ifj?src=rss